                         SEQUENCE LISTING

<110>  Ohio State Innovation Foundation
 
<120>  PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION

<130>  10336-459WO1

<160>  28    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  1

Glx Ile Glx Ile Thr 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  2

Val Ile Val Ile Thr 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  3

Val Ile Glx Ile Thr 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  homovaline

<400>  4

Xaa Ile Xaa Ile Thr 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  5

Glx Ile Val Ile Thr 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Beta-hydroxyvaline

<400>  6

Xaa Ile Xaa Ile Thr 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  cyclohexylglycine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Beta-hydroxyvaline

<400>  7

Xaa Xaa Xaa Ile Thr 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  penicillamine sulfonic acid

<400>  8

Xaa Ile Xaa Ile Thr 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  cyclohexylglycine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  penicillamine sulfonic acid

<400>  9

Xaa Xaa Xaa Ile Thr 
1               5   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Glutamic acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  4-fluorophenylalanine

<400>  10

Xaa Ile Xaa Ile Thr Tyr Xaa Xaa Gly 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-leucine

<400>  11

Xaa Ile Xaa Ile Thr Gln His Xaa His 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tert-butyl-alanine

<400>  12

Xaa Ile Xaa Ile Thr Asp Gln Tyr Arg 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-leucine

<400>  13

Xaa Ile Xaa Ile Thr Gln His Xaa Ser 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tert-butyl-alanine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-lysine

<400>  14

Xaa Ile Xaa Ile Thr Asp Gln Tyr Xaa 
1               5                   


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-arginine

<400>  15

Lys Xaa Phe Arg Xaa Arg Xaa Asp 
1               5               


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  2,3-diaminopropionic acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-arginine

<400>  16

Xaa Xaa Phe Arg Xaa Arg Xaa Asp 
1               5               


<210>  17
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-proline

<400>  17

Arg Val Arg Thr Arg Gly Lys Arg Arg Ile Arg Arg Xaa Pro 
1               5                   10                  


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-proline

<400>  18

Arg Thr Arg Thr Arg Gly Lys Arg Arg Ile Arg Val Xaa Pro 
1               5                   10                  


<210>  19
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  19

Trp Arg Trp Arg Trp Arg Trp Arg 
1               5               


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  dodecanoyl

<400>  20

Lys Xaa Arg Arg Arg Arg 
1               5       


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  21

Cys Arg Cys Arg Cys Arg Cys Arg 
1               5               


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (2)..(4)
<223>  L-2,3-diaminopropionic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(8)
<223>  L-2,3-diaminopropionic acid

<400>  22

Thr Xaa Xaa Xaa Xaa Leu Xaa Xaa Thr 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  L-2-amino-3-guanidinylpropionic acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  L-2,3-diaminopropionic acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  L-2-amino-3-guanidinylpropionic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(8)
<223>  L-2-amino-3-guanidinylpropionic acid

<400>  23

Thr Xaa Xaa Xaa Xaa Leu Xaa Xaa Thr 
1               5                   


<210>  24
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  24

Gly Pro His Pro 
1               


<210>  25
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  25

Gly Pro His Glu Glu 
1               5   


<210>  26
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  26

Gly Pro His Pro Glx Ile Glx Ile Thr Gly Pro His Glu Glu Tyr Lys 
1               5                   10                  15      


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  27

Glx Ile Glx Ile Thr Gly Pro 
1               5           


<210>  28
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic construct

<400>  28

Glx Ile Glx Ile Thr Gly Pro His Glu Glu Tyr Lys 
1               5                   10          


